Higher and broader immunogenicity following MF59-adjuvanted influenza vaccination (Fluad®) in at-risk adults (18-60 years of age) a randomized, controlled, observer-blind study

Authors
Publication date
1 January 2009
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Padova

    redirect
    oaioai:www.research.unipd.it:1157...
    Last time updated on 12/11/2016